Fumio Imamura
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 123 publications
Targeted RNA sequencing enhances the integrated diagnosis of bone and soft tissue tumors.
Journal: Human pathology
Published: October 16, 2025
Apocrine carcinoma of the breast: distinctive metabolic reprogramming and high-frequency PIK3CA mutations revealed by molecular and immunohistochemical analysis.
Journal: Histopathology
Published: May 21, 2025
Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report.
Journal: Frontiers in oncology
Published: October 09, 2024
Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.
Journal: Nature communications
Published: June 01, 2023
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 12, 2022
Fragment size and dynamics of EGFR-mutated tumor-derived DNA provide prognostic information regarding EGFR-TKI efficacy in patients with EGFR-mutated NSCLC.
Journal: Scientific reports
Published: January 13, 2022
RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With EGFR-Mutated Metastatic NSCLC.
Journal: JTO clinical and research reports
Published: December 16, 2021
Last Updated: 09/26/2026